Landmark TrialRCTRandomized Controlled Trial
Tumor biology remains the main determinant of prognosis in retroperitoneal sarcomas: a 14‐year single‐center experience
Asia-Pacific Journal of Clinical Oncology2017IF: 0.8
Deanna Ng, Grace Hwei Ching Tan, Claramae Shulyn Chia, Soo Khee Chee, Richard Quek, Mohamad Farid, Melissa Ching Ching Teo
Abstract
An aggressive surgical approach in primary and recurrent RPS is associated with good OS. Complete resection, with contiguous organ resection if necessary should be performed to achieve microscopically negative surgical margins to allow for long-term survival. However, tumor biology remains the main determinant for OS.